GENEVA, SWITZERLAND / ACCESSWIRE / October 21, 2024 / RELIEF THERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF)(OTCQB:RLFTY ) (Relief, or the Company), a…
WINNIPEG, Manitoba, Oct. 17, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that…
ATI-1701 provides full protection against lethal tularemia in animal models after one year Company to provide update on tularemia vaccine…
New Resin Eliminates >99.9% of Bacteria and Fungi In Vitro That Lead to Biofilm and Denture Stomatitis in 3D-Printed DenturesNEWPORT…
Dr. Diwan to Discuss "Shape-Shifting", "Trojan Horse", Pathogen-Directed Attack Capability of NanoViricides Platform Technology to Combat AMR SHELTON, CT /…
Program developed by Medavera, Inc. will take place during IDWeek 2024LOS ANGELES, CA / ACCESSWIRE / October 6, 2024 /…
WINNIPEG, Manitoba, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech”, “Kane” or the “Company”)…
JERSEY CITY, N.J., Oct. 03, 2024 (GLOBE NEWSWIRE) -- SCYNEXIS, Inc. (NASDAQ: SCYX), a biotechnology company pioneering innovative medicines to…
DSMC has reviewed the safety and pharmacokinetic data from Cohort 2 and recommended that the study proceed to enroll patients…
HACKENSACK, NJ/ ACCESSWIRE / October 1, 2024 / Royal Wound-X, a division of Royal Biologics, is proud to announce that…